CASI Pharmaceuticals has entered into agreements to build a state-of-the-art manufacturing site in the Wuxi Huishan Economic Development Zone in Jiangsu Province, China. The Wuxi Huishan Economic Development Zone is a science and technology innovation center in the region.   The facility will be designed and constructed based on global cGMP requirements and is expected to have capacity for large-scale production. The facility will be a key asset supporting CASI’s growth and commercializa...